Literature DB >> 20430897

Common and uncommon pathogenic cascades in lysosomal storage diseases.

Einat B Vitner1, Frances M Platt, Anthony H Futerman.   

Abstract

Lysosomal storage diseases (LSDs), of which about 50 are known, are caused by the defective activity of lysosomal proteins, resulting in accumulation of unmetabolized substrates. As a result, a variety of pathogenic cascades are activated such as altered calcium homeostasis, oxidative stress, inflammation, altered lipid trafficking, autophagy, endoplasmic reticulum stress, and autoimmune responses. Some of these pathways are common to many LSDs, whereas others are only altered in a subset of LSDs. We now review how these cascades impact upon LSD pathology and suggest how intervention in the pathways may lead to novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20430897      PMCID: PMC2898325          DOI: 10.1074/jbc.R110.134452

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Batten disease (JNCL) is linked to disturbances in mitochondrial, cytoskeletal, and synaptic compartments.

Authors:  Kaisu Luiro; Outi Kopra; Tomas Blom; Massimiliano Gentile; Hannah M Mitchison; Iiris Hovatta; Kid Törnquist; Anu Jalanko
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

2.  NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.

Authors:  Mylvaganam Jeyakumar; David A Smith; Ian M Williams; Mario Cortina Borja; David C A Neville; Terry D Butters; Raymond A Dwek; Frances M Platt
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

3.  Innate and adaptive immune activation in the brain of MPS IIIB mouse model.

Authors:  Julianne DiRosario; Erin Divers; Chuansong Wang; Jonathan Etter; Alyssa Charrier; Peter Jukkola; Herbert Auer; Victoria Best; David L Newsom; Douglas M McCarty; Haiyan Fu
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

4.  ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones.

Authors:  Hui Wei; Sung-Jo Kim; Zhongjian Zhang; Pei-Chih Tsai; Krystyna E Wisniewski; Anil B Mukherjee
Journal:  Hum Mol Genet       Date:  2007-11-07       Impact factor: 6.150

Review 5.  Neuronal ceroid lipofuscinoses.

Authors:  Anu Jalanko; Thomas Braulke
Journal:  Biochim Biophys Acta       Date:  2008-11-24

6.  Mucopolysaccharidosis IIIB: oxidative damage and cytotoxic cell involvement in the neuronal pathogenesis.

Authors:  Guglielmo R D Villani; Carmela Di Domenico; Annapaola Musella; Francesca Cecere; Daniele Di Napoli; Paola Di Natale
Journal:  Brain Res       Date:  2009-05-03       Impact factor: 3.252

Review 7.  Glycosphingolipids in endocytic membrane transport.

Authors:  Dan J Sillence; Frances M Platt
Journal:  Semin Cell Dev Biol       Date:  2004-08       Impact factor: 7.727

8.  Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.

Authors:  Dori Pelled; Emyr Lloyd-Evans; Christian Riebeling; Mylvaganam Jeyakumar; Frances M Platt; Anthony H Futerman
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

Review 9.  Immune response in leukodystrophies.

Authors:  Florian Eichler; Keith Van Haren
Journal:  Pediatr Neurol       Date:  2007-10       Impact factor: 3.372

Review 10.  Lysosomal disorders: from storage to cellular damage.

Authors:  Andrea Ballabio; Volkmar Gieselmann
Journal:  Biochim Biophys Acta       Date:  2008-12-08
View more
  142 in total

1.  Single cell ganglioside catabolism in primary cerebellar neurons and glia.

Authors:  David C Essaka; Jillian Prendergast; Richard B Keithley; Ole Hindsgaul; Monica M Palcic; Ronald L Schnaar; Norman J Dovichi
Journal:  Neurochem Res       Date:  2012-03-11       Impact factor: 3.996

2.  Elevation of GM2 ganglioside during ethanol-induced apoptotic neurodegeneration in the developing mouse brain.

Authors:  Mitsuo Saito; Goutam Chakraborty; Relish Shah; Rui-Fen Mao; Asok Kumar; Dun-Sheng Yang; Kostantin Dobrenis; Mariko Saito
Journal:  J Neurochem       Date:  2012-03-20       Impact factor: 5.372

Review 3.  Gene therapy for the neurological manifestations in lysosomal storage disorders.

Authors:  Seng H Cheng
Journal:  J Lipid Res       Date:  2014-03-29       Impact factor: 5.922

4.  A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis.

Authors:  Mohammad Samie; Xiang Wang; Xiaoli Zhang; Andrew Goschka; Xinran Li; Xiping Cheng; Evan Gregg; Marlene Azar; Yue Zhuo; Abigail G Garrity; Qiong Gao; Susan Slaugenhaupt; Jim Pickel; Sergey N Zolov; Lois S Weisman; Guy M Lenk; Steve Titus; Marthe Bryant-Genevier; Noel Southall; Marugan Juan; Marc Ferrer; Haoxing Xu
Journal:  Dev Cell       Date:  2013-08-29       Impact factor: 12.270

Review 5.  Lysosomal physiology.

Authors:  Haoxing Xu; Dejian Ren
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

Review 6.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

Review 7.  Lysosomal storage diseases.

Authors:  Frances M Platt; Alessandra d'Azzo; Beverly L Davidson; Elizabeth F Neufeld; Cynthia J Tifft
Journal:  Nat Rev Dis Primers       Date:  2018-10-01       Impact factor: 52.329

8.  Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Authors:  Jameson J Ribbens; Ann B Moser; Walter C Hubbard; Ernesto R Bongarzone; Gustavo H B Maegawa
Journal:  Mol Genet Metab       Date:  2013-09-21       Impact factor: 4.797

Review 9.  Neuronal membrane dynamics as fine regulator of sphingolipid composition.

Authors:  Massimo Aureli; Maura Samarani; Nicoletta Loberto; Elena Chiricozzi; Laura Mauri; Sara Grassi; Domitilla Schiumarini; Alessandro Prinetti; Sandro Sonnino
Journal:  Glycoconj J       Date:  2018-08-25       Impact factor: 2.916

10.  Biomarkers of bone remodeling in children with mucopolysaccharidosis types I, II, and VI.

Authors:  David A Stevenson; Kyle Rudser; Alicia Kunin-Batson; Ellen B Fung; David Viskochil; Elsa Shapiro; Paul J Orchard; Chester B Whitley; Lynda E Polgreen
Journal:  J Pediatr Rehabil Med       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.